Published on: November 29, 2017 at 10:30PM
Conditions: Breast Cancer; Triple Negative Breast Cancer; Luminal B
Interventions: Drug: Paclitaxel; Drug: Epirubicin; Drug: Cyclophosphamide; Drug: Durvalumab
Sponsors: Grand Hôpital de Charleroi; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting
http://ift.tt/2Ah85dg
New cancer clinical trial: Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Tag: cancer Clinical Trials
No comments: